Tradewinds Capital Management, LLC Novavax Inc Transaction History

Tradewinds Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 21, 2022	SELL	$36.28 - $75.29 $22,167 - $46,002	-611 Closed	0 $0
Q4 2021 Feb 02, 2022	BUY	$134.56 - $217.97 $54,496 - $88,277	405 Added 196.6%	611 $87,000
Q3 2021 Nov 04, 2021	SELL	$177.8 - $270.58 $72,898 - $110,937	-410 Reduced 66.56%	206 $43,000
Q2 2021 Jul 30, 2021	BUY	$121.0 - $257.67 $49,610 - $105,644	410 Added 199.03%	616 $131,000
Q1 2021 Apr 23, 2021	BUY	$112.98 - $319.93 $677 - $1,919	6 Added 3.0%	206 $37,000
Q3 2020 Oct 26, 2020	BUY	$79.44 - $178.51 $15,888 - $35,702	200 New	200 $22,000

292

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $630M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Tradewinds Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Tradewinds Capital Management, LLC with notifications on news.